BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20693395)

  • 1. Tongxinluo reduces myocardial no-reflow and ischemia-reperfusion injury by stimulating the phosphorylation of eNOS via the PKA pathway.
    Li XD; Yang YJ; Geng YJ; Jin C; Hu FH; Zhao JL; Zhang HT; Cheng YT; Qian HY; Wang LL; Zhang BJ; Wu YL
    Am J Physiol Heart Circ Physiol; 2010 Oct; 299(4):H1255-61. PubMed ID: 20693395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of endothelial NOS contributes to simvastatin protection against myocardial no-reflow and infarction in reperfused swine hearts: partially via the PKA signaling pathway.
    Li XD; Yang YJ; Geng YJ; Zhao JL; Zhang HT; Cheng YT; Wu YL
    Acta Pharmacol Sin; 2012 Jul; 33(7):879-87. PubMed ID: 22659627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PKA-mediated eNOS phosphorylation in the protection of ischemic preconditioning against no-reflow.
    Li XD; Cheng YT; Yang YJ; Meng XM; Zhao JL; Zhang HT; Wu YJ; You SJ; Wu YL
    Microvasc Res; 2012 Jul; 84(1):44-54. PubMed ID: 22542438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase A-mediated cardioprotection of Tongxinluo relates to the inhibition of myocardial inflammation, apoptosis, and edema in reperfused swine hearts.
    Li XD; Yang YJ; Cheng YT; Dou KF; Tian Y; Meng XM
    Chin Med J (Engl); 2013; 126(8):1469-79. PubMed ID: 23595379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tongmai Yangxin pill reduces myocardial no-reflow by regulating apoptosis and activating PI3K/Akt/eNOS pathway.
    Chen R; Chen T; Wang T; Dai X; Meng K; Zhang S; Jiang D; Wang Y; Zhou K; Geng T; Xu J; Wang Y
    J Ethnopharmacol; 2020 Oct; 261():113069. PubMed ID: 32619593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiomyocyte-derived small extracellular vesicles can signal eNOS activation in cardiac microvascular endothelial cells to protect against Ischemia/Reperfusion injury.
    Chen G; Xu C; Gillette TG; Huang T; Huang P; Li Q; Li X; Li Q; Ning Y; Tang R; Huang C; Xiong Y; Tian X; Xu J; Xu J; Chang L; Wei C; Jin C; Hill JA; Yang Y
    Theranostics; 2020; 10(25):11754-11774. PubMed ID: 33052245
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of tongxinluo on endothelin-1 in the mini-swine model of acute myocardial infarction and reperfusion].
    Zhao JL; Yang YJ; You SJ; Jin Z; Wu Y; Yang W; Chen J; Gao R; Chen Z
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Oct; 25(10):902-6. PubMed ID: 16313114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cardioprotection of simvastatin in reperfused swine hearts relates to the inhibition of myocardial edema by modulating aquaporins via the PKA pathway.
    Li XD; Yang YJ; Geng YJ; Cheng YT; Zhang HT; Zhao JL; Yuan JQ; Gao RL
    Int J Cardiol; 2013 Sep; 167(6):2657-66. PubMed ID: 22819122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac microvascular barrier function mediates the protection of Tongxinluo against myocardial ischemia/reperfusion injury.
    Qi K; Li L; Li X; Zhao J; Wang Y; You S; Hu F; Zhang H; Cheng Y; Kang S; Cui H; Duan L; Jin C; Zheng Q; Yang Y
    PLoS One; 2015; 10(3):e0119846. PubMed ID: 25781461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment with Tongxinluo protects porcine myocardium from ischaemia/reperfusion injury through a nitric oxide related mechanism.
    Cheng YT; Yang YJ; Zhang HT; Qian HY; Zhao JL; Meng XM; Luo FL; Wu YL
    Chin Med J (Engl); 2009 Jul; 122(13):1529-38. PubMed ID: 19719943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of tongxinluo ultramicro-pulverization on myocardial post-reperfusion no-reflow in mini-swine model of acute myocardial infarction].
    Yang YJ; Zhao JJ; Meng L
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Jan; 26(1):49-53. PubMed ID: 16466173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tongxinluo exerts protective effects via anti-apoptotic and pro-autophagic mechanisms by activating AMPK pathway in infarcted rat hearts.
    Li Q; Li N; Cui HH; Tian XQ; Jin C; Chen GH; Yang YJ
    Exp Physiol; 2017 Apr; 102(4):422-435. PubMed ID: 28150462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early ischaemic preconditioning requires Akt- and PKA-mediated activation of eNOS via serine1176 phosphorylation.
    Yang C; Talukder MA; Varadharaj S; Velayutham M; Zweier JL
    Cardiovasc Res; 2013 Jan; 97(1):33-43. PubMed ID: 22977010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tongxinluo decreases apoptosis of mesenchymal stem cells concentration-dependently under hypoxia and serum deprivation conditions through the AMPK/eNOS pathway.
    Li N; Yang YJ; Cui HH; Zhang Q; Jin C; Qian HY; Dong QT; Zhang H
    J Cardiovasc Pharmacol; 2014 Mar; 63(3):265-73. PubMed ID: 24220313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway.
    Bulhak AA; Jung C; Ostenson CG; Lundberg JO; Sjöquist PO; Pernow J
    Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H719-27. PubMed ID: 19151258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tongxinluo protects against pressure overload-induced heart failure in mice involving VEGF/Akt/eNOS pathway activation.
    Wang B; Yang Q; Bai WW; Xing YF; Lu XT; Sun YY; Zhao YX
    PLoS One; 2014; 9(6):e98047. PubMed ID: 24887083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of ligustrazine against myocardial ischaemia reperfusion in rats: the role of endothelial nitric oxide synthase.
    Lv L; Jiang SS; Xu J; Gong JB; Cheng Y
    Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):20-7. PubMed ID: 22004361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective Effects of Shenfu Injection against Myocardial Ischemia-Reperfusion Injury via Activation of eNOS in Rats.
    Wang YY; Li YY; Li L; Yang DL; Zhou K; Li YH
    Biol Pharm Bull; 2018 Sep; 41(9):1406-1413. PubMed ID: 29910216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.
    Gonon AT; Widegren U; Bulhak A; Salehzadeh F; Persson J; Sjöquist PO; Pernow J
    Cardiovasc Res; 2008 Apr; 78(1):116-22. PubMed ID: 18222959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tongxinluo attenuates reperfusion injury in diabetic hearts by angiopoietin-like 4-mediated protection of endothelial barrier integrity via PPAR-α pathway.
    Qi K; Li X; Geng Y; Cui H; Jin C; Wang P; Li Y; Yang Y
    PLoS One; 2018; 13(6):e0198403. PubMed ID: 29912977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.